Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;74(12):2199-2201.
doi: 10.47391/JPMA.24-101.

Radiation-Induced Leukoencephalopathy in Glioma Patients

Syed Faisal Nadeem  1 , Hania Fatima  2 , Zanib Javed  1 , Muhammad Shahzad Shamim  1
Affiliations
Free article
Review

Radiation-Induced Leukoencephalopathy in Glioma Patients

Syed Faisal Nadeem et al. J Pak Med Assoc. 2024 Dec.
Free article

Abstract

Radiation-induced leukoencephalopathy (RIL) is a late complication of cerebral radiation therapy (CRT) used in treating gliomas. It involves progressive damage to the brain's white matter, seen as T2/FLAIR hyperintensity on MRI. Risk factors include age, high radiation doses, and cumulative exposure. RIL is caused by mitochondrial dysfunction, blood-brain barrier disruption, and oligodendrocyte apoptosis, leading to neurocognitive decline, ranging from mild memory issues to severe dementia. While no cure exists, treatment focuses on managing symptoms, and research is exploring ways to minimize risk through lower radiation doses and targetted therapies. This review aims to summarize key findings on RIL, focusing on its epidemiology, pathogenesis, clinical manifestations, and existing treatments.

Keywords: Radiation-induced leukoencephalopathy, Radiation, Glioma, Degeneration, Oligodendrocyte..

PubMed Disclaimer